Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page
- Check6 days agoChange DetectedRevision label on the page was updated from v3.5.3 to v3.5.4, indicating a new build of the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s footer revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov site release rather than a change to the trial record content.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a system-level update with no visible changes to the study details or other user-facing content.SummaryDifference0.0%

- Check100 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2; no impact on study content or page usability.SummaryDifference0.0%

Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.